Oligomeric State of β-Coronavirus Non-Structural Protein 10 Stimulators Studied by Small Angle X-ray Scattering.
COVID-19
SARS-CoV-2
SAXS
conformational changes
non-structural proteins
nsp10
oligomeric state
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
04 Sep 2023
04 Sep 2023
Historique:
received:
29
06
2023
revised:
23
08
2023
accepted:
25
08
2023
medline:
11
9
2023
pubmed:
9
9
2023
entrez:
9
9
2023
Statut:
epublish
Résumé
The β-coronavirus family, encompassing Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Severe Acute Respiratory Syndrome Coronavirus (SARS), and Middle East Respiratory Syndrome Coronavirus (MERS), has triggered pandemics within the last two decades. With the possibility of future pandemics, studying the coronavirus family members is necessary to improve knowledge and treatment. These viruses possess 16 non-structural proteins, many of which play crucial roles in viral replication and in other vital functions. One such vital protein is non-structural protein 10 (nsp10), acting as a pivotal stimulator of nsp14 and nsp16, thereby influencing RNA proofreading and viral RNA cap formation. Studying nsp10 of pathogenic coronaviruses is central to unraveling its multifunctional roles. Our study involves the biochemical and biophysical characterisation of full-length nsp10 from MERS, SARS and SARS-CoV-2. To elucidate their oligomeric state, we employed a combination of Multi-detection Size exclusion chromatography (Multi-detection SEC) with multi-angle static light scattering (MALS) and small angle X-ray scattering (SAXS) techniques. Our findings reveal that full-length nsp10s primarily exist as monomers in solution, while truncated versions tend to oligomerise. SAXS experiments reveal a globular shape for nsp10, a trait conserved in all three coronaviruses, although MERS nsp10, diverges most from SARS and SARS-CoV-2 nsp10s. In summary, unbound nsp10 proteins from SARS, MERS, and SARS-CoV-2 exhibit a globular and predominantly monomeric state in solution.
Identifiants
pubmed: 37686452
pii: ijms241713649
doi: 10.3390/ijms241713649
pmc: PMC10563069
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : MRC - UCL Therapeutic Acceleration Support (TAS) and the MRC DPFS
ID : MR/X013995/1
Organisme : Royal Physiographic Society of Lund and the Erik Philip-Sörensen Foundation
Références
Nat Commun. 2021 Jun 2;12(1):3287
pubmed: 34078893
Cells. 2021 Apr 06;10(4):
pubmed: 33917481
Int J Mol Sci. 2020 Oct 06;21(19):
pubmed: 33036230
Viruses. 2021 Jun 13;13(6):
pubmed: 34199223
J Virol. 2006 Aug;80(16):7902-8
pubmed: 16873247
Proc Natl Acad Sci U S A. 2021 Jun 15;118(24):
pubmed: 34045361
Nat Commun. 2021 Jan 12;12(1):279
pubmed: 33436624
Proc Natl Acad Sci U S A. 2015 Jul 28;112(30):9436-41
pubmed: 26159422
Nucleic Acids Res. 2014 Jul;42(Web Server issue):W320-4
pubmed: 24753421
Nucleic Acids Res. 2021 May 21;49(9):5382-5392
pubmed: 33956156
Sci Adv. 2023 Mar 29;9(13):eade8778
pubmed: 36989354
Acta Pharmacol Sin. 2022 Dec;43(12):3021-3033
pubmed: 35058587
Sci Signal. 2021 Jun 29;14(689):
pubmed: 34131072
Antiviral Res. 2023 Feb;210:105501
pubmed: 36567022
Nat Commun. 2022 Mar 17;13(1):1547
pubmed: 35301314
Nat Commun. 2020 Jul 24;11(1):3717
pubmed: 32709887
Cell. 2021 Jun 24;184(13):3474-3485.e11
pubmed: 34143953
Biophys J. 1999 Jun;76(6):2879-86
pubmed: 10354416
EBioMedicine. 2022 Aug;82:104158
pubmed: 35834885
Science. 2021 Dec 24;374(6575):1586-1593
pubmed: 34726479
Expert Opin Ther Pat. 2021 Apr;31(4):339-350
pubmed: 33593200
J Virol. 2006 Aug;80(16):7894-901
pubmed: 16873246
J Vis Exp. 2019 Jun 20;(148):
pubmed: 31282880
J Appl Crystallogr. 2021 Feb 01;54(Pt 1):343-355
pubmed: 33833657
Virol Sin. 2016 Feb;31(1):3-11
pubmed: 26847650
PLoS Pathog. 2011 May;7(5):e1002059
pubmed: 21637813
Nat Commun. 2020 Jul 24;11(1):3718
pubmed: 32709886
J Synchrotron Radiat. 2020 Sep 1;27(Pt 5):1438-1446
pubmed: 32876621
RSC Chem Biol. 2021 Oct 6;3(1):44-55
pubmed: 35128408
Structure. 2022 Aug 4;30(8):1050-1054.e2
pubmed: 35609600
Biophys J. 2005 Aug;89(2):1237-50
pubmed: 15923225
Lancet Infect Dis. 2020 Sep;20(9):e238-e244
pubmed: 32628905
Bioinformatics. 2018 Jun 1;34(11):1944-1946
pubmed: 29300836
BMJ. 2021 Feb 18;372:n494
pubmed: 33602668
Nucleic Acids Res. 2013 Jul;41(Web Server issue):W597-600
pubmed: 23671338
J Virol. 2021 Aug 10;95(17):e0040221
pubmed: 34133899
J Appl Crystallogr. 2009 Apr 1;42(Pt 2):342-346
pubmed: 27630371
Methods Mol Biol. 2015;1282:1-23
pubmed: 25720466